CytoDel, INC.
Pharmaceutical company · New York, United States
CytoDel, INC. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2012. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $934,229 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $3.9 million sold in a notice filed in 2018.
CytoDel at a glance
What does CytoDel do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $934,229 in total (2014 to 2023). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $3.9 million sold (2018).
Frequently asked questions about CytoDel
Where is CytoDel headquartered?
CytoDel, INC. is headquartered in New York, United States.
What does CytoDel do?
CytoDel, INC. is a pharmaceutical company.
When was CytoDel founded?
The earliest incorporation on record for CytoDel, INC. is in 2012, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences